Close Menu
    Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Contracts + Grants

    Big-Data Competition Opens to Help Children at Risk for Severe COVID-19

    By Global Biodefense StaffAugust 20, 2021
    Photo credit: HHS ASPR
    Share
    Facebook LinkedIn Reddit Email

    Methods to distinguish children at risk for severe COVID-19 complications, including conditions such as MIS-C are needed to enable development of early interventions to improve pediatric patient outcomes.

    About 1 in 3 children hospitalized with COVID-19 in the United States were admitted to the intensive care unit, similar to the rate among adults.

    While most children with COVID-19 are asymptomatic or have mild symptoms, healthcare providers have difficulty determining which of their pediatric patients will progress to moderate or severe COVID-19 early in the progression. Some of these patients develop multisystem inflammatory syndrome in children (MIS-C), a life-threatening inflammation of organs and tissues. Methods to distinguish children at risk for severe COVID-19 complications, including conditions such as MIS-C are needed for earlier interventions to improve pediatric patient outcomes.

    The U.S. Department of Health and Human Services (HHS) has launched a data challenge competition that will leverage de-identified electronic health record data to develop, train and validate computational models that can predict severe COVID-19 complications in children, equipping healthcare providers with the information and tools they need to identify pediatric patients at risk.

    The challenge is sponsored by the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Office of the Assistant Secretary for Preparedness and Response, in partnership with two institutes from the National Institutes of Health – the National Institute of Health’s National Center for Advancing Translational Sciences (NCATS) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) – along with the Health Resources and Services Administration’s (HRSA) Maternal and Child Health Bureau. The challenge will be administered by Sage Bionetworks.

    Challenge participants will be asked to develop, train, and validate computational models to predict pediatric patients at risk for hospitalization, need for ventilation, and cardiovascular interventions, utilizing de-identified electronic health record data available through NCATS’ National COVID Cohort Collaborative (N3C) Data Enclave. The N3C Data Enclave is a central, harmonized data repository that represents electronic health records from over 55 health centers across the U.S. To protect patient privacy, de-identified data provides information useful to researchers without revealing any information that could identify individual patients.

    The total cash prize purse is $200,000 split among up to three winners. Winners also may be eligible to apply for follow on funding support and in-kind services from BARDA for further technology development and clinical evaluation.

    Pediatric COVID-19 Data Challenge Timeline

    Aug. 19 – Onboarding Phase
    Sep. 15 – Round 1 Begins
    Oct. 12 – Round 2 Begins
    Oct 26 – Registration deadline to request access to challenge within N3C
    Dec 17 – End Round 1 & 2 (extended from Nov. 19)
    TBD – Winners Announced
    TBD – Collaboration Phase Begins

    To learn more about the challenge, including challenge rules, eligibility, criteria for winning entries, data enclave use requirements, and how to register to join the N3C consortium, visit the Challenge.gov page. Because fully registering for the N3C consortium can take several weeks, potential participants are encouraged to review the requirements, rules, criteria, and timelines for each competition phase as soon as possible.

    BARDA Bioinformatics COVID-19 Editor Pick Innovation Medicine-Health Opportunities Request for Proposals
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleThird COVID-19 Wave in Mexico Shows Dangers of Weak Federal Response
    Next Article After India’s Brutal Pandemic Wave, Two-Thirds of Population Has Been Exposed to SARS-CoV-2

    Related Stories

    First Light Diagnostics Receives FDA Clearance for Rapid Anthrax Test

    December 5, 2023

    Chlorine Exposure Biomarkers in a Large Animal Model

    December 5, 2023

    ARPA-H Announces New Tiered Proposal Submission System to Reduce Applicant Barriers

    December 5, 2023

    Needle-Free Vaccine Patch Against Zika Virus

    December 2, 2023
    News Scan

    Biodefense Headlines – 30 November 2023

    News Scan November 30, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include the largest ever outbreak of mpox in the DRC; launch of National Wastewater Surveillance Program dashboard; low uptake of COVID-19 boosters and flu vaccines;…

    Upcoming Events

    Mar 12
    Hybrid Hybrid Event
    March 12, 2024 - March 17, 2024

    2024 Fungal Genetics Conference

    Mar 21
    March 21, 2024 - March 23, 2024

    ASPPH 2024 Annual Meeting

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    News on pathogens and preparedness for public health emergencies

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    Global Biodefense places cookies on your device to enable the best user experience. By using our website, you agree to placement of these cookies. To learn more, read our Privacy Policy.OKPrivacy Policy